The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2025

Filed:

Jul. 25, 2019
Applicant:

Alteogen Inc., Daejeon, KR;

Inventors:

Soon Jae Park, Daejeon, KR;

Hye-Shin Chung, Daejeon, KR;

Seung Joo Lee, Daejeon, KR;

Sun-Ah You, Daejeon, KR;

Hyung-Nam Song, Daejeon, KR;

Chang Woo Lee, Daejeon, KR;

Assignee:

ALTEOGEN Inc., Daejeon, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); A61K 45/06 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2402 (2013.01); A61K 45/06 (2013.01); C07K 14/00 (2013.01); C12Y 302/01035 (2013.01);
Abstract

The present invention is related to the field of protein engineering technology which increases the enzymatic activity and thermal stability of human hyaluronidase which is an enzyme that hydrolyzes hyaluronic acid; and more particularly to hyaluronidase PH20 variants or fragments thereof, which comprise one or more amino acid residue substitutions in the region corresponding to the alpha-helix region and its linker region in the amino acid sequence of wild-type PH20 of SEQ ID NO: 1 and in which one or more amino acid residues at the N-terminus and/or the C-terminus are selectively cleaved additionally. Specifically, the present invention relates to PH20 variants or fragments thereof, which comprise one or more amino acid residue substitutions selected from the group consisting of T341A, T341C, T341G, S343E, M345T, K349E, L353A, L354I, N356E and I361T in wild-type PH20 having the amino acid sequence of SEQ ID NO: 1, and additionally comprise the substitution of amino acids located in the alpha-helix 8 region and/or a linker region between alpha-helix 7 and alpha-helix 8 in the amino acid sequence of wild-type PH20, and in which one or more amino acids located at the N-terminal and C-terminal regions are deleted.


Find Patent Forward Citations

Loading…